KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lam Research (LRCX) Operating Income (2016 - 2025)

Historic Operating Income for Lam Research (LRCX) over the last 17 years, with Q4 2025 value amounting to $1.8 billion.

  • Lam Research's Operating Income rose 3570.92% to $1.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $6.9 billion, marking a year-over-year increase of 4518.06%. This contributed to the annual value of $5.9 billion for FY2025, which is 3839.33% up from last year.
  • Latest data reveals that Lam Research reported Operating Income of $1.8 billion as of Q4 2025, which was up 3570.92% from $1.8 billion recorded in Q3 2025.
  • In the past 5 years, Lam Research's Operating Income ranged from a high of $1.8 billion in Q3 2025 and a low of $854.6 million during Q2 2023
  • Over the past 5 years, Lam Research's median Operating Income value was $1.3 billion (recorded in 2021), while the average stood at $1.3 billion.
  • Per our database at Business Quant, Lam Research's Operating Income soared by 7412.84% in 2021 and then plummeted by 4223.12% in 2023.
  • Quarter analysis of 5 years shows Lam Research's Operating Income stood at $1.3 billion in 2021, then rose by 25.56% to $1.7 billion in 2022, then plummeted by 37.08% to $1.1 billion in 2023, then increased by 26.17% to $1.3 billion in 2024, then soared by 35.71% to $1.8 billion in 2025.
  • Its last three reported values are $1.8 billion in Q4 2025, $1.8 billion for Q3 2025, and $1.7 billion during Q2 2025.